Beckman Coulter Was the Hematology Market Leader in 2015 with Almost Half of the Entire Market According to US Market for Hematology Devices - 2016 (Forecasted to 2022)

Nov 12, 2015, 19:10 ET from Research and Markets

DUBLIN, Nov. 12, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/4v389f/us_market_for) has announced the addition of the "US Market for Hematology Devices - 2016 (Forecasted to 2022)" report to their offering.

Hematology analyzers discussed in this market include low-volume and high-volume systems. Low- volume systems, commonly found in decentralized labs, smaller commercial labs, physician office labs (POLs) and other near patient clinics, are three-part differentials and compact in size with cell counting as their primary function. High-volume analyzers, found in core labs and large reference labs, include additional parameters and typically have microscopy or image-processing capabilities.

The high-volume analyzer market is at a mature stage due to extended life spans and improved durability of the systems; growth opportunities, however, exist in the low-volume segment, particularly in the POL market, due to the emergence of the outcomes-based health care delivery, which is resulting in higher volumes of testing being done during the patient visits owing to the advantages of early detection and timely treatment.

On the other hand, the growth of hematology testing in smaller private labs, POLs and other near patient clinics will be challenged by the implementation of the market-based fee adjustments to the CMS Clinical Laboratory Fee Schedule (CLFS), beginning January 2017. Consequently, one of the most routine high-volume lab tests, the complete blood count (CBC), is expected to witness lower reimbursements due to the economies of scale and low costs in large automated private labs and core labs of hospitals, which account for more than 65% of the hematology testing. Consequently, rates paid by CMS and private insurance players may not account for the higher costs to perform the tests in POLs and smaller clinics.

Beckman Coulter was the hematology market leader in 2015 with almost half of the entire market. Their high end analyzers and low end analyzers meet the needs of nearly any hematology testing environment. Close competitors in this space include Sysmex America, Abbott Diagnostics, Siemens Healthcare Diagnostics, Horiba, and others.

This Report includes extensive detail on: - High Volume Hematology Analyzer Market - Lower Volume Hematology Analyzer Market - Hematology Reagent Market

This Report Also Includes:

- In-depth, Professionally Researched Data That Has Been Formatted and Analyzed to Gain Actionable Insights as Quickly as Possible

- Executive Summary

- Trend Analysis by Segment

- Market Value Forecasts until 2022 and History Back to 2012

- Market Drivers and Limiters

- Detailed Competitive Analysis for Each Market and Segment

Key Topics Covered:

1. Executive Summary

2. Research Methodology

3. Hematology Market

4. Abbreviations

Companies Mentioned

- Abbott Diagnostics

- Beckman Coulter

- Horiba

- Siemens Healthcare Diagnostics

- Sysmex America

For more information visit

http://www.researchandmarkets.com/research/4v389f/us_market_for

Media Contact:

Laura Wood, +353-1-481-1716, press@researchandmarkets.net

 

SOURCE Research and Markets



RELATED LINKS

http://www.researchandmarkets.com